IGAM
REGN icon

iA Global Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

iA Global Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6M Sell
20,154
-492
-2% -$335K 0.15% 119
2026
Q1 		$16M Sell
20,646
-368
-2% -$282K 0.23% 96
2025
Q4 		$16.2M Buy
21,014
+766
+4% +$520K 0.21% 104
2025
Q3 		$11.4M Buy
20,248
+1,008
+5% +$570K 0.16% 115
2025
Q2 		$10.1M Buy
19,240
+6
+0% +$3.35K 0.15% 116
2025
Q1 		$12.2M Buy
19,234
+7,586
+65% +$5.22M 0.21% 89
2024
Q4 		$8.3M Sell
11,648
-1,538
-12% -$1.29M 0.15% 114
2024
Q3 		$13.9M Buy
13,186
+2,541
+24% +$2.83M 0.24% 78
2024
Q2 		$11.2M Sell
10,645
-2,177
-17% -$2.11M 0.21% 82
2024
Q1 		$12.3M Buy
12,822
+3,188
+33% +$3.03M 0.25% 81
2023
Q4 		$8.46M Buy
9,634
+737
+8% +$607K 0.2% 93
2023
Q3 		$7.32M Sell
8,897
-486
-5% -$382K 0.19% 101
2023
Q2 		$6.74M Buy
+9,383
New +$7.23M 0.18% 105

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

iA Global Asset Management's REGN Position: Q2 2026 in Review

iA Global Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 2.4% in Q2 2026, selling an estimated $335K and leaving 20,154 shares worth $12.6M. The position accounts for 0.15% of the portfolio, ranked #119.

iA Global Asset Management first reported a position in REGN in Q2 2023 and has held it in 13 quarters since. The position peaked at $16.2M in Q4 2025. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • iA Global Asset Management held 20,154 shares of Regeneron Pharmaceuticals worth $12.6M as of Q2 2026.
  • iA Global Asset Management sold 492 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $335K.
  • Regeneron Pharmaceuticals made up 0.15% of iA Global Asset Management's portfolio in Q2 2026, its #119 holding.
  • iA Global Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • iA Global Asset Management's Regeneron Pharmaceuticals position peaked at $16.2M in Q4 2025.
  • 1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on iA Global Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.